AAVs and RNA in Vaccine Development

What is one of the innovative approaches being explored for COVID-19 therapy?

• Homeopathy

• Herbal medicine

• Gene therapy using viruses

• Traditional vaccine development

What is the primary goal of a vaccine?

• To expose the immune system to antigens safely

• To eliminate the virus completely

• To provide immediate relief from symptoms

• To cure the disease

What is convalescent plasma used for in COVID-19 treatment?

• To hydrate patients

• To provide nutrients to patients

• To replace lost blood

• To transfer antibodies from recovered patients

What is a challenge in using RNA for vaccine development?

• RNA is too expensive to produce

• RNA can be broken down quickly in the body

• RNA is not effective in triggering an immune response

• RNA is difficult to store

What is the role of adeno-associated viruses (AAVs) in gene therapy?

• To cause disease

• To act as a vaccine

• To deliver genetic material into cells

• To replace damaged cells

Why are AAVs considered suitable for gene therapy?

• They are naturally occurring in humans

• They cause severe diseases

• They are large and complex

• They can be engineered to deliver DNA without replicating

What is a potential downside of AAV-based gene therapy?

• It is a permanent solution

• It permanently edits germ cells

• It is ineffective in all cases

• It may have long-term side effects

Why might the cost of AAV-based therapy for COVID-19 be lower than for other diseases?

• It uses cheaper materials

• It is easier to produce

• It requires less research

• It targets a larger market

What is the current status of AAV-based COVID-19 vaccine trials?

• They are in preclinical trials

• They have been approved

• They have been abandoned

• They are in human trials

What is the main advantage of using AAVs in gene therapy?

• They are easy to produce

• They do not cause disease

• They are naturally occurring

• They are inexpensive